We investigated whether determination in fine-needle aspiration biopsy (FNAB) specimens of cells expressing granzymes (Grs) and Fas ligand would provide a reliable, easy, and quantitative measure of rejection activity in the transplanted liver. Retrospectively, 13 FNAB specimens obtained during clinical acute rejection, 10 FNAB specimens obtained during subclinical rejection, 12 FNAB specimens obtained during cytomegalovirus (CMV) infection, and 26 FNAB specimens obtained in the absence of rejection or infection were included on the study. Cytospin preparations of FNAB and peripheral-blood specimens were immunocytochemically stained for Fas-ligand and Gr, and increments in the liver were calculated by subtracting frequencies of positive cells in blood from those in FNAB specimens. Only sporadically Fas ligand-expressing, but many Gr-expressing, cells were detected in FNAB specimens. Increments in Gr-positive (Gr(+)) cells were significantly greater in FNAB specimens obtained during clinical rejection (median, 70 Gr(+) cells; range, 0 to 312 Gr(+) cells; P = .006) and tended to be greater in FNAB specimens obtained during subclinical rejection (median, 62 Gr(+) cells; range, 5 to 113 Gr(+) cells; P = .09) compared with those obtained in the absence of rejection (median, 16 Gr(+) cells; range, 0 to 103 Gr(+) cells). Increments obtained during clinical or subclinical rejection did not differ from those obtained during CMV infection (median, 27 Gr(+) cells; range, 6 to 212 Gr(+) cells). With the exclusion of specimens obtained during CMV infection, the sensitivity of Gr determination in FNAB specimens for the diagnosis of acute rejection (either clinical or subclinical) was 70%, and specificity, 69%. In FNAB specimens obtained during clinical and subclinical acute rejection episodes after liver transplantation, increased numbers of Gr-expressing cells were present; in the absence of CMV infection, their quantification provides a measure for rejection activity with moderate accuracy.

Download full-text PDF

Source
http://dx.doi.org/10.1053/jlts.2002.34970DOI Listing

Publication Analysis

Top Keywords

fnab specimens
44
gr+ cells
36
acute rejection
16
cmv infection
16
median gr+
16
cells range
16
specimens
13
cells
13
rejection
12
fnab
12

Similar Publications

Background: The diagnosis of malignant thyroid nodules is mainly based on the fine-needle aspiration biopsy (FNAB). To improve the detection of malignant nodules, different molecular tests have been developed. We present a new molecular signature based on altered miRNA expressions and specific mutations.

View Article and Find Full Text PDF
Article Synopsis
  • - Ex vivo fluorescence laser scanning microscopy (FCM) enables real-time imaging of fresh tissue samples without traditional slide preparation, and this study specifically investigates its application in evaluating biopsy samples from endoscopic procedures for lung lesions and lymph nodes.
  • - The study involved 32 patients, showing that the FCM Vivascope 2500 could accurately assess sample adequacy and malignancy, with a perfect agreement noted between its evaluations and final histological results.
  • - The findings suggest that FCM could significantly improve the speed of diagnostic information during endoscopic biopsies, potentially enhancing patient management by reducing the time needed to diagnose lung cancer.
View Article and Find Full Text PDF
Article Synopsis
  • Fine-needle aspiration biopsy (FNAB) is the best method to evaluate thyroid nodules, but non-diagnostic results can lead to delays, unnecessary procedures, and stress for patients.
  • * The study aimed to analyze the relationship between patients' anxiety levels, pain perception, and the occurrence of non-diagnostic cytology results during FNAB.
  • * Results indicated that higher anxiety and pain scores were significantly associated with non-diagnostic outcomes, suggesting that alleviating these factors could improve diagnostic accuracy.
View Article and Find Full Text PDF

Xpert Breast Cancer STRAT4 Assay using fine-needle aspiration biopsy samples in a resource-constrained setting: a prospective diagnostic accuracy study.

Lancet Oncol

November 2024

Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.

Article Synopsis
  • A study was conducted to evaluate the STRAT4 Assay's effectiveness using fine-needle aspiration biopsy (FNAB) samples for breast cancer testing in Tanzania, aiming to improve biomarker accessibility in low-resource settings.
  • The research involved collecting FNAB specimens from patients with palpable breast masses, using various testing protocols and excluding those with previous breast cancer diagnoses or specific conditions like pregnancy.
  • The analysis compared STRAT4's performance against established testing methods based on factors like concordance, sensitivity, specificity, and diagnostic accuracy over a three-year period involving 208 patients.
View Article and Find Full Text PDF

Endoscopic Ultrasound-Guided Fine Needle Acquisition for Evaluation of Pancreatic Neuroendocrine Tumors: A Meta-Analysis.

J Clin Gastroenterol

September 2024

Department of Gastroenterology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou.

Aims: The aim of this meta-analysis was to assess the diagnostic performance of EUS-FNA/B in patients with panNETs.

Methods: We conducted a computerized search of the MEDLINE and Embase databases to identify relevant articles. The primary outcomes involved grading concordance rate, diagnostic rate, and correlation coefficient (Cohen's κ) for FNA/B samples compared with surgical specimens.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!